Navigation Links
PARI's eFlow Delivers Alnylam RNAi Therapeutic in Phase II Study
Date:4/17/2008

MONTEREY, Calif., April 17 /PRNewswire/ -- An optimized PARI eFlow platform nebulizer will be delivering Alnylam's ALN-RSV01 in a Phase II human clinical trial that has begun enrolling patients. ALN-RSV01 is a RNAi therapeutic being developed as a treatment for respiratory syncytial virus (RSV) infection, the leading cause of pediatric hospitalization in the U.S. and a prevalent infection in immune-compromised adults. RSV currently does not have a viable treatment option.

"The progression into Phase II clinical trials with Alnylam's therapeutic is significant as it is the first RNAi program in clinical trials using inhalation. We are seeing a number of companies turn to advanced nebulization with our eFlow platform, because the flexibility allows the development of new respiratory therapies that are delivered to the lungs in a faster, more effective manner," said Geoff A. Hunziker, President of eFlow LLC.

Respiratory syncytial virus (RSV) is a highly contagious virus that causes infections in the upper and lower respiratory tract associated with predictable seasonal outbreaks worldwide. RSV infection is the most common cause for infant hospitalization (more than 100,000 hospitalizations annually in the U.S.), and the virus is a significant pathogen in the elderly. The RNAi therapeutic agent ALN-RSV01 is a small interfering ribonucleic acid (siRNA) targeting the messenger RNA of the RSV N gene to prevent viral replication. To deliver ALN-RSV01 to the site of infection, the RNA therapeutic is being administered as an aerosol in a highly efficient pulmonary delivery system, an optimized eFlow platform nebulizer, with high drug output, optimized droplet size, and low residual drug loss.

For more information on the Phase II study, visit http://www.alnylam.com.

About eFlow

eFlow, an electronic, portable nebulizer platform, enables extremely efficient aerosolization of liquid medic
'/>"/>

SOURCE PARI Pharma
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Cleveland Clinic to Lead First Head-to-Head Comparison of the Two Most Potent Statins
2. PARIs eFlow Included in Gileads NDA Submission for Aztreonam Lysine for Inhalation
3. New Analysis of Study Data Shows That Asacol(R) (Mesalamine) Delivers Rapid Symptom Relief for Ulcerative Colitis Patients
4. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
5. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
6. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
7. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
8. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
9. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
10. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
11. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... , July 24, 2014 /PRNewswire-iReach/ -- Delivery of ... order is placed. Photo - ... professional and in-depth market survey on Global and ... the basic information of Hemodialysis Machine including its ... explores global and China,s top manufacturers of Hemodialysis ...
(Date:7/24/2014)... July 24, 2014   Royal Philips (NYSE: ... it has received 510(k) clearance from the U.S. Food ... ultrasound system, VISIQ, in the U.S. VISIQ ... benefits of greater mobility, performance and simplicity into a ... diagnostic scans for more OB patients. This ...
(Date:7/24/2014)... 24, 2014  Bruin Biometrics (BBI), a pioneer ... after two weeks of clinical briefings to over ... it gained substantial concurrence on both the clinical ... utility of BBI,s SEM Scanner. ... the respondents drawn from the European Wound Management ...
Breaking Medicine Technology:Hemodialysis Machine Industry for Global and Chinese Markets Forecast to 2019 2Hemodialysis Machine Industry for Global and Chinese Markets Forecast to 2019 3Hemodialysis Machine Industry for Global and Chinese Markets Forecast to 2019 4Hemodialysis Machine Industry for Global and Chinese Markets Forecast to 2019 5Philips receives FDA 510(k) clearance for its innovative ultra mobile VISIQ ultrasound system 2Philips receives FDA 510(k) clearance for its innovative ultra mobile VISIQ ultrasound system 3Bruin Biometrics Secures Support of EU Scientific Community for its SEM Scanner Technology 2
... , Consumers Oppose Prescription Mandate; Prefer Alternative Method to ... Jan. 30 Mississippians are expressing outrage at lawmakers, ... (PSE) to a prescription (Rx) drug. , "The Consumer ... Mississippians to contact their legislators which within the first day ...
... Jan. 29 The IKF,s (International Kids Fund) ... Children called the " Haiti ,s Children Fund."  It will ... Memorial Hospital for life-saving medical care.  Donations may be made ... program of the Jackson Memorial Foundation, whose mission is to ...
Cached Medicine Technology:Mississippians React to Rushed Pseudoephedrine Debate Raging in the State Legislature 2Mississippians React to Rushed Pseudoephedrine Debate Raging in the State Legislature 3IKF's Wonderfund(TM) Needs Support for Haiti's Children 2
(Date:7/24/2014)... (Boston)--Minority women who received the Human Papillomavirus Vaccination ... rates of abnormal Pap test results than those ... the journal Sexually Transmitted Diseases . ... Health and School of Medicine conducted a cross-sectional ... undergoing routine cervical cytology testing. HPV status and ...
(Date:7/24/2014)... On October 24-25th, 2014, hundreds of women ... Embassy Suites LAX North for DiabetesSisters’ power-packed weekend conference. This ... first time it has convened Los Angeles, CA area. It ... open the entire event to both women with diabetes and ... kind worldwide for women with diabetes, the event offers opportunities ...
(Date:7/24/2014)... low-income families vouchers to buy fruits and vegetables at ... foods, according to a new study. Low-income families ... to not having adequate access to healthy foods, cost ... address both of these obstacles, the researchers noted. ... may be able to bring a low-income person onto ...
(Date:7/24/2014)... babies are at risk for autism because they have an ... ways to detect Autism Spectrum Disorder (ASD) earlier in life, ... and how they relate to the possibility and severity of ... the connection between early joint attention before one year and ... communication that develops toward the end of the first year. ...
(Date:7/24/2014)... (PRWEB) July 24, 2014 ACRIA & AMIDA ... BROOKS, , Save the Dates: August 7th ... are excited to cohost “A Dialogue for Life” forums this ... the White House Office of National AIDS Policy (ONAP). This ... efforts being made locally by AIDS organizations, consumers and advocates ...
Breaking Medicine News(10 mins):Health News:DiabetesSisters Brings Conference for Women with Diabetes Los Angeles for the First Time 2Health News:DiabetesSisters Brings Conference for Women with Diabetes Los Angeles for the First Time 3Health News:Farmers' Market Vouchers May Help Poorer Families Eat Healthier 2Health News:Early warning sign for babies at risk of autism 2Health News:White House Office of National AIDS Policy Hosts Public Forums in NYC Aug. 7 and 8, Sponsored by Amida Care and ACRIA 2Health News:White House Office of National AIDS Policy Hosts Public Forums in NYC Aug. 7 and 8, Sponsored by Amida Care and ACRIA 3
... IBS 2 times more likely in people with depression , , ... link between allergies and irritable bowel syndrome (IBS) in adults, ... in Chicago. , IBS occurs in about 15 percent of ... may lead to IBS symptoms in some patients, but the ...
... that run off the land and mix in rivers and ... on the salmon nervous system. These pesticides are widely used ... the food supply for humans may also pose an unexpected ... on how to assess the health effects of single chemicals ...
... Cory Watson Crowder &,DeGaris, P.C. (http://www.cwcd.com ), ... plaintiffs throughout the United States, who allegedly suffered,permanent ... drug used to prevent excessive bleeding during coronary,artery ... commonly bypass).,According to CBS News, 60 Minutes will ...
... to fight off a common sexually transmitted disease and increase ... to a new study. No such association is seen, however, ... loss, and the bodys response to the infection. , Human ... common subtype of the virus is HPV16. Infection with HPV16 ...
... 2 strains found, health officials still recommend inoculation , , ... now exists in virtually every state, and many of ... covered by this year,s influenza vaccine, U.S. health officials ... influenza activity in the early part of the season, ...
... New Report to be Released at Press Conference, ... CHICAGO, Feb. 15 U.S. Senator Dick Durbin,(D-IL) ... at the Chicago Children,s Museum on February 20 to ... advantage of the lack of,government regulation and have unleashed ...
Cached Medicine News:Health News:Allergy Disorders Linked With Irritable Bowel Syndrome 2Health News:60 Minutes to Report on Dangers of Trasylol: Cory Watson Crowder & DeGaris Involved in Litigation Against Pharmaceutical Giant Bayer AG 2Health News:Stress may increase a woman's risk of developing cervical cancer 2Health News:Flu Widespread in U.S., but Vaccine Is Poor Match 2Health News:Sen. Durbin & Public Health Leaders Call for Legislation to Protect Kids from Tobacco 2
CRP Liquid Conrtols level 2...
The AMY method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of amylase activity in serum, plasma and urine....
The GLU method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of glucose in serum, plasma, urine and cerebrospinal fluid....
Enzymatic Clearance assay for the in vitro quantitative determination of LDL-cholesterol in human serum and plasma....
Medicine Products: